1. Home
  2. SRPT vs CMPO Comparison

SRPT vs CMPO Comparison

Compare SRPT & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • CMPO
  • Stock Information
  • Founded
  • SRPT 1980
  • CMPO 2000
  • Country
  • SRPT United States
  • CMPO United States
  • Employees
  • SRPT N/A
  • CMPO N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • CMPO Finance: Consumer Services
  • Sector
  • SRPT Health Care
  • CMPO Finance
  • Exchange
  • SRPT Nasdaq
  • CMPO Nasdaq
  • Market Cap
  • SRPT 1.9B
  • CMPO 2.1B
  • IPO Year
  • SRPT 1997
  • CMPO N/A
  • Fundamental
  • Price
  • SRPT $23.50
  • CMPO $19.69
  • Analyst Decision
  • SRPT Hold
  • CMPO Strong Buy
  • Analyst Count
  • SRPT 31
  • CMPO 6
  • Target Price
  • SRPT $40.61
  • CMPO $18.83
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • CMPO 712.8K
  • Earning Date
  • SRPT 11-05-2025
  • CMPO 11-07-2025
  • Dividend Yield
  • SRPT N/A
  • CMPO N/A
  • EPS Growth
  • SRPT N/A
  • CMPO N/A
  • EPS
  • SRPT N/A
  • CMPO N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • CMPO $267,817,999.00
  • Revenue This Year
  • SRPT $9.41
  • CMPO $10.30
  • Revenue Next Year
  • SRPT N/A
  • CMPO $8.12
  • P/E Ratio
  • SRPT N/A
  • CMPO N/A
  • Revenue Growth
  • SRPT 64.89
  • CMPO N/A
  • 52 Week Low
  • SRPT $10.42
  • CMPO $9.24
  • 52 Week High
  • SRPT $138.81
  • CMPO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 62.33
  • CMPO 48.65
  • Support Level
  • SRPT $21.93
  • CMPO $19.06
  • Resistance Level
  • SRPT $23.87
  • CMPO $20.89
  • Average True Range (ATR)
  • SRPT 1.42
  • CMPO 0.71
  • MACD
  • SRPT 0.10
  • CMPO -0.17
  • Stochastic Oscillator
  • SRPT 71.58
  • CMPO 31.06

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About CMPO CompoSecure Inc.

CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.

Share on Social Networks: